US Stock MarketDetailed Quotes

Enanta Pharmaceuticals (ENTA)

Watchlist
  • 12.200
  • -0.320-2.56%
Close Sep 18 16:00 ET
  • 12.200
  • 0.0000.00%
Post 19:30 ET
355.33MMarket Cap-5.04P/E (TTM)

Enanta Pharmaceuticals (ENTA) Income Statement

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: USD
2026/Q3
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
2022/Q3
2022/Q2
2022/Q1
2021/Q4
Total Revenue as Reported
-21.60%14.36M
+14.96%17.16M
+9.76%18.62M
+3.55%15.13M
+1.91%18.31M
-12.48%14.93M
-5.80%16.96M
-22.84%14.61M
-4.88%17.97M
-4.16%17.05M
-23.67%18.00M
-6.82%18.93M
-3.01%18.89M
-4.92%17.80M
-14.70%23.59M
-13.82%20.32M
-9.92%19.48M
-7.03%18.72M
-12.90%27.65M
-0.24%23.58M
Total Operating Revenue
-21.60%14.36M
+14.96%17.16M
+9.76%18.62M
+3.55%15.13M
+1.91%18.31M
-12.48%14.93M
-5.80%16.96M
-22.84%14.61M
-4.88%17.97M
-4.16%17.05M
-23.67%18.00M
-6.82%18.93M
-3.01%18.89M
-4.92%17.80M
-14.70%23.59M
-13.82%20.32M
-9.92%19.48M
-7.03%18.72M
-12.90%27.65M
-0.24%23.58M
Operating Expense
-15.08%31.60M
-26.47%29.01M
-26.26%29.87M
-24.63%33.51M
-11.74%37.21M
-20.81%39.45M
-23.42%40.50M
-11.01%44.46M
-24.19%42.16M
-12.97%49.82M
-1.32%52.89M
+5.48%49.96M
+6.89%55.61M
+8.91%57.25M
-7.68%53.60M
-17.34%47.37M
-6.22%52.02M
+5.48%52.56M
+31.82%58.06M
+31.99%57.30M
Selling and Admin Expenses
-5.28%9.47M
-15.98%9.57M
-29.87%9.01M
-29.09%9.70M
-25.47%10.00M
-20.00%11.39M
-22.23%12.85M
-0.81%13.68M
+6.31%13.41M
+3.32%14.24M
+30.10%16.52M
+9.75%13.80M
-2.41%12.62M
+31.52%13.78M
+33.53%12.70M
+50.42%12.57M
+52.52%12.93M
+25.82%10.48M
+28.89%9.51M
+24.20%8.36M
-General & Admin Expense
-5.28%9.47M
-15.98%9.57M
-29.87%9.01M
-29.09%9.70M
-25.47%10.00M
-20.00%11.39M
-22.23%12.85M
-0.81%13.68M
+6.31%13.41M
+3.32%14.24M
+30.10%16.52M
+9.75%13.80M
-2.41%12.62M
+31.52%13.78M
+33.53%12.70M
+50.42%12.57M
+52.52%12.93M
+25.82%10.48M
+28.89%9.51M
+24.20%8.36M
Research & Development
-18.68%22.13M
-30.72%19.44M
-24.58%20.86M
-22.64%23.81M
-5.33%27.21M
-21.13%28.07M
-23.96%27.66M
-14.90%30.78M
-33.14%28.74M
-18.14%35.59M
-11.08%36.37M
+3.94%36.17M
+9.97%42.99M
+3.28%43.47M
-15.75%40.90M
-28.91%34.80M
-16.82%39.09M
+1.40%42.09M
+32.41%48.55M
+33.42%48.95M
Operating Profit
+8.77%-17.24M
+51.68%-11.85M
+52.20%-11.25M
+38.41%-18.39M
+21.88%-18.89M
+25.14%-24.53M
+32.51%-23.54M
+3.79%-29.85M
+34.12%-24.19M
+16.95%-32.77M
-16.24%-34.89M
-14.72%-31.03M
-12.82%-36.71M
-16.56%-39.45M
+1.30%-30.01M
+19.80%-27.05M
+3.86%-32.54M
-13.96%-33.85M
-147.25%-30.41M
-70.48%-33.73M
Net Non-Operating Interest Income (Expense)
-434.18%-2.23M
-313.15%-1.23M
-178.97%-661.00K
-153.95%-321.00K
-41.08%667.00K
-53.61%578.00K
-2.33%837.00K
-60.67%595.00K
-39.43%1.13M
-32.17%1.25M
-13.70%857.00K
+139.78%1.51M
+375.57%1.87M
+620.39%1.84M
--993.00K
--631.00K
--393.00K
--255.00K
----
----
Non-Operating Interest Income
-16.81%1.90M
-9.08%2.08M
-13.47%2.42M
-34.95%2.07M
-34.47%2.29M
-39.83%2.29M
-34.88%2.80M
-31.90%3.18M
-9.80%3.49M
+107.35%3.81M
+332.83%4.30M
+639.14%4.66M
+883.72%3.87M
+620.39%1.84M
--993.00K
--631.00K
--393.00K
--255.00K
----
----
Non-Operating Interest Expense
+155.25%4.13M
+93.47%3.32M
+57.14%3.08M
-7.52%2.39M
-31.30%1.62M
-33.13%1.71M
-42.98%1.96M
-18.09%2.58M
+17.93%2.36M
--2.56M
--3.44M
--3.15M
--2.00M
--0.00
--0.00
--0.00
--0.00
----
----
----
Other Income (Expense)
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-61.89%258.00K
+68.28%-1.69M
Other Non-Operating Income (Expenses)
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-61.89%258.00K
---1.69M
Pretax Profit
-6.80%-19.47M
+45.37%-13.08M
+47.53%-11.91M
+36.04%-18.67M
+20.94%-18.23M
+24.02%-23.95M
+33.27%-22.71M
+1.12%-29.19M
+33.84%-23.05M
+16.20%-31.52M
-17.26%-34.03M
-12.09%-29.52M
-8.39%-34.84M
-11.97%-37.61M
+3.75%-29.02M
+21.14%-26.33M
+3.77%-32.15M
-15.22%-33.59M
-159.43%-30.15M
-79.21%-33.39M
Tax
+24.14%36.00K
+100.54%7.00K
+105.77%24.00K
+108.82%32.00K
+107.34%29.00K
-259.50%-1.31M
+33.12%-416.00K
+74.26%-363.00K
-109.36%-395.00K
-925.00%-363.00K
-1729.41%-622.00K
-10171.43%-1.41M
+1044.30%4.22M
--44.00K
+5.56%-34.00K
+100.16%14.00K
+95.24%-447.00K
+100.00%0.00
+98.91%-36.00K
-182.14%-8.80M
Net Profit
-6.83%-19.50M
+42.19%-13.09M
+46.44%-11.94M
+35.12%-18.70M
+19.43%-18.26M
+27.32%-22.64M
+33.28%-22.29M
-2.55%-28.82M
+42.00%-22.66M
+17.26%-31.16M
-15.25%-33.41M
-6.68%-28.11M
-23.23%-39.07M
-12.10%-37.66M
+3.75%-28.99M
-7.11%-26.35M
-31.95%-31.70M
-52.38%-33.59M
-261.61%-30.12M
+16.16%-24.60M
Profit from Continuing Operations
-6.83%-19.50M
+42.19%-13.09M
+46.44%-11.94M
+35.12%-18.70M
+19.43%-18.26M
+27.32%-22.64M
+33.28%-22.29M
-2.55%-28.82M
+42.00%-22.66M
+17.26%-31.16M
-15.25%-33.41M
-6.68%-28.11M
-23.23%-39.07M
-12.10%-37.66M
+3.75%-28.99M
-7.11%-26.35M
-31.95%-31.70M
-52.38%-33.59M
-261.61%-30.12M
+16.16%-24.60M
Net Income to Parent Company
-6.83%-19.50M
+42.19%-13.09M
+46.44%-11.94M
+35.12%-18.70M
+19.43%-18.26M
+27.32%-22.64M
+33.28%-22.29M
-2.55%-28.82M
+42.00%-22.66M
+17.26%-31.16M
-15.25%-33.41M
-6.68%-28.11M
-23.23%-39.07M
-12.10%-37.66M
+3.75%-28.99M
-7.11%-26.35M
-31.95%-31.70M
-52.38%-33.59M
-261.61%-30.12M
+16.16%-24.60M
Net Income to Common Stockholders
-6.83%-19.50M
+42.19%-13.09M
+46.44%-11.94M
+35.12%-18.70M
+19.43%-18.26M
+27.32%-22.64M
+33.28%-22.29M
-2.55%-28.82M
+42.00%-22.66M
+17.26%-31.16M
-15.25%-33.41M
-6.68%-28.11M
-23.23%-39.07M
-12.10%-37.66M
+3.75%-28.99M
-7.11%-26.35M
-31.95%-31.70M
-52.38%-33.59M
-261.61%-30.12M
+16.16%-24.60M
Basic EPS
+21.18%-0.67
+57.55%-0.45
+60.00%-0.42
+36.03%-0.87
+20.56%-0.85
+27.89%-1.06
+33.54%-1.05
-2.26%-1.36
+42.47%-1.07
+17.88%-1.47
-13.67%-1.58
-4.72%-1.33
-21.57%-1.86
-9.82%-1.79
+6.08%-1.39
-4.10%-1.27
-28.57%-1.53
-49.54%-1.63
-260.98%-1.48
+16.44%-1.22
Diluted EPS
+21.18%-0.67
+57.55%-0.45
+60.00%-0.42
+36.03%-0.87
+20.56%-0.85
+27.89%-1.06
+33.54%-1.05
-2.26%-1.36
+42.47%-1.07
+17.88%-1.47
-13.67%-1.58
-4.72%-1.33
-21.57%-1.86
-9.82%-1.79
+6.08%-1.39
-4.10%-1.27
-28.57%-1.53
-49.54%-1.63
-260.98%-1.48
+16.44%-1.22
Deadline
Jun 30, 2026
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Accounting Standard
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
2026/Q32026/Q22026/Q12025/Q42025/Q32025/Q22025/Q12024/Q42024/Q32024/Q22024/Q12023/Q42023/Q32023/Q22023/Q12022/Q42022/Q32022/Q22022/Q12021/Q4
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On September 1, U.S. Eastern Time, the U.S. military launched a new round of strikes against Iran in response to recent attempts by the Isla Show More